JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
APGE
4426
DELISTED
Apogee Therapeutics
APGE
| $644K | ﹤0.01% |
23,064
+9,830
| +74% | +$197K |
2023 Q3
1 quarter
|
|
4427
MannKind Corp
MNKD
$1.22B
| $642K | ﹤0.01% |
176,406
+683
| +0.4% | +$2.61K |
2016 Q4
28 quarters
|
|
4428
Invesco Global Water ETF
PIO
$262M
| $642K | ﹤0.01% |
16,229
+16,216
| +124,738% | +$569K |
2023 Q2
2 quarters
|
|
4429
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.79B
| $639K | ﹤0.01% |
7,672
+4,725
| +160% | +$349K |
2022 Q1
7 quarters
|
|
4430
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
$389M
| $638K | ﹤0.01% |
13,455
-2,019
| -13% | -$85.5K |
2022 Q3
5 quarters
|
|
4431
Invesco S&P 500 Pure Value ETF
RPV
$1.66B
| $638K | ﹤0.01% |
7,777
-3,874
| -33% | -$290K |
2013 Q2
42 quarters
|
|
4432
Blend Labs
BLND
$244M
| $638K | ﹤0.01% |
250,105
+248,425
| +14,787% | +$375K |
2021 Q3
9 quarters
|
|
4433
State Street SPDR S&P Telecom ETF
XTL
$552M
| $637K | ﹤0.01% |
7,969
+775
| +11% | +$54.7K |
2016 Q1
31 quarters
|
|
4434
CALL
Arista Networks
ANET
$262B
| $636K | ﹤0.01% |
+10,800
| New | +$567K |
2023 Q4
0 quarters
|
|
|
CTEV
4435
Claritev Corp
CTEV
$402M
| $635K | ﹤0.01% |
11,027
+536
| +5% | +$32.5K |
2020 Q3
13 quarters
|
|
4436
Gilat Satellite Networks
GILT
$773M
| $635K | ﹤0.01% |
103,946
-37
| -0% | -$230 |
2019 Q3
17 quarters
|
|
4437
CALL
UiPath
PATH
$6.84B
| $633K | ﹤0.01% |
25,500
| – | – |
2023 Q3
1 quarter
|
|
4438
PUT
Strategy Inc
MSTR
$63.8B
| $632K | ﹤0.01% |
10,000
-41,000
| -80% | -$1.94M |
2023 Q1
3 quarters
|
|
|
ALPN
4439
DELISTED
Alpine Immune Sciences Inc
ALPN
| $630K | ﹤0.01% |
33,074
+1,765
| +6% | +$24.5K |
2021 Q2
10 quarters
|
|
|
ABLG
4440
Abacus FCF International Leaders ETF
ABLG
$14.6M
| $630K | ﹤0.01% |
21,617
+20,686
| +2,222% | +$565K |
2023 Q3
1 quarter
|
|
4441
PUT
Travere Therapeutics
TVTX
$5.37B
| $629K | ﹤0.01% |
+70,000
| New | +$510K |
2023 Q4
0 quarters
|
|
|
OSG
4442
Octave Specialty Group
OSG
$207M
| $625K | ﹤0.01% |
37,942
-27,535
| -42% | -$383K |
2013 Q2
42 quarters
|
|
4443
Overlay Shares Hedged Large Cap Equity ETF
OVLH
$108M
| $619K | ﹤0.01% |
21,427
+5,854
| +38% | +$161K |
2023 Q1
3 quarters
|
|
4444
Carlyle Secured Lending
CGBD
$733M
| $619K | ﹤0.01% |
41,374
+19,824
| +92% | +$288K |
2018 Q2
22 quarters
|
|
4445
CALL
Sunrun
RUN
$1.86B
| $618K | ﹤0.01% |
31,500
+200
| +0.6% | +$2.54K |
2021 Q2
10 quarters
|
|
4446
DocGo
DCGO
$36.6M
| $618K | ﹤0.01% |
110,501
+8,047
| +8% | +$46.2K |
2022 Q2
6 quarters
|
|
4447
CALL
Groupon
GRPN
$785M
| $618K | ﹤0.01% |
48,100
-4,500
| -9% | -$54K |
2023 Q2
2 quarters
|
|
4448
Pacer Data & Infrastructure Real Estate ETF
SRVR
$320M
| $617K | ﹤0.01% |
20,701
+20,659
| +49,188% | +$562K |
2023 Q2
2 quarters
|
|
|
LPSN
4449
DELISTED
LivePerson
LPSN
| $614K | ﹤0.01% |
10,807
+3,803
| +54% | +$175K |
2016 Q3
29 quarters
|
|
4450
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$458M
| $613K | ﹤0.01% |
6,676
+1,826
| +38% | +$156K |
2022 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.